With a new CRISPR gene-editing methodology, scientists from the University of Illinois at Urbana-Champaign inactivated one of the genes responsible for an inherited form of amyotrophic lateral sclerosis – a debilitating and fatal neurological disease for which there is no cure. The novel treatment slowed disease progression, improved muscle function and extended lifespan in mice with an aggressive form of ALS.
“ALS unfortunately has few treatment options. This is an important first step in showing that this new form of gene editing could be used to potentially treat the disease,” said bioengineering professor Thomas Gaj, who co-led the study with bioengineering professor Pablo Perez-Pinera.
The method relied on an emerging gene-editing technology known as CRISPR base editors.
Traditional CRISPR gene-editing technologies cut both strands of a DNA molecule, which can introduce a variety of errors in the DNA sequence, limiting its efficiency and potentially leading to a number of unintended mutations in the genome. The Illinois group instead used base editing “to change one letter of the DNA sequence to another without cutting through both DNA strands,” Perez-Pinera said.
“Base editors are too large to be delivered into cells with one of the most promising and successful gene therapy vectors, known as adeno-associated virus,” Gaj said. However, in 2019, Perez-Pinera’s group developed a method of splitting the base editor proteins into halves that can be delivered by two separate AAV particles. Once inside the cell, the halves reassemble into the full-length base editor protein.
By combining the power of AAV gene delivery and split-base editors, Gaj and Perez-Pinera targeted and permanently disabled a mutant SOD1 gene, which is responsible for roughly 20% of inherited forms of ALS. They published their results in the journal Molecular Therapy.
“Many ALS studies are focused on preventing or delaying the onset of the disease. However, in the real world, most patients are not diagnosed until symptoms are advanced,” said graduate student Colin Lim. “Slowing progression, rather than preventing it, may have a greater impact on patients.” Lim is the co-first author of the study along with graduate students Michael Gapinske and Alexandra Brooks.
The Latest Updates from Bing News & Google News
Go deeper with Bing News on:
Lou Gehrig’s disease
- From e-biz tycoon to ALS patient: a man's race against the disease From e-biz tycoon to ALS patient: a man's race against the disease
There is still no cure for ALS, but Cai is determined to find one not only for himself but also for fellow patients around the world.
- Does blue-green algae cause Lou Gehrig's disease?
Could the blue-green algae that plagues much of our water in South Florida and the Treasure Coast cause Lou Gehrig’s disease? Researchers from Arizona State University say there is a strong connection ...
- New ASU study links ALS (Lou Gehrig's disease) and toxic cyanobacteria algal blooms
ASU study finds "strong association" between BMAA, a toxin found in cyanobacteria, and ALS, commonly called Lou Gehrig's disease.
- Lou Gehrig's disease
Adeona Names New Managers, Eyes Name ChangeAdeona Pharmaceuticals Inc. has swapped bosses as it continues testing new drugs for multiple sclerosis, fibromyalgia and Lou Gehrig's disease.
- Tommy Smith’s battle with Lou Gehrig’s disease
more commonly know as Lou Gehrig’s Disease. The diagnosis ultimately forced Smith to step away from the baseball field. “I wouldn’t wish this on my worst enemy,” Smith’s wife ...
Go deeper with Google Headlines on:
Lou Gehrig’s disease
Go deeper with Bing News on:
- FDA Releases Action Plan for Rare Neurodegenerative Diseases, Including ALS
Plan Fulfills a Requirement of the Accelerating Access to Critical Therapies for ALS Act SILVER SPRING, Md., June 23, 2022 /PRNewswire/ -- Today, the U.S. Food and Drug Administration unveiled its ...
- St. Louis School of Medicine wants public to join ALS study
Join a study on ALS diagnosis at the Washington University St. Louis School of Medicine. ALS stands for Amyotrophic Lateral Sclerosis and causes progressive and deadly loss of muscle control. The ALS ...
- Duterte Legacy: No one left behind in quality education via ALS
The limiting effect of unplanned circumstances on access to quality education has undoubtedly affected literacy in the Philippines, as the administration of outgoing President Rodrigo Duterte pushed ...
- ALS May Be Linked to Both the Immune and Nervous Systems
A team at Mount Sinai has reported that amyotrophic lateral sclerosis may be caused by both nervous and immune system dysfunctions.
- Americans With ALS Look to Canada for Promising Drug the U.S. Hasn’t Approved
The Food and Drug Administration is still considering whether to permit Albrioza, but some Americans diagnosed with Lou Gehrig’s disease aren’t inclined to wait.